ICIS is implementing a process of rolling consultation on all of its pricing methodologies. This consultation paper is part of this formal process and covers all of the ICIS primary price points included in the methyl isobutyl ketone weekly publications.

The consultation asks both general questions about the suitability of the ICIS pricing methodology and questions addressing specific methyl isobutyl ketone market issues.

Click here to view the Methyl Isobutyl Ketone Methodology Consultation 2021

ICIS Decision

There were no formal responses to consultation GMC 51/21 ICIS will not be proposing any immediate changes to the methodology of the methyl isobutyl ketone report. Any decision to change this methodology will be communicated to subscribers using the usual channels and with the usual notice period.

ICIS continues to welcome any feedback on its methodology outside of the formal consultation process.

To provide further comments or feedback please contact Barbara Ortner, Head of Market Reporting:

Consultation on this document closed on 1 October 2021